Log in

Transcriptomic Expression of T2-Inflammation Genes in Peripheral Blood Mononuclear Cells and Longitudinal Clinical Outcomes in Asthma: Insights from the COREA Study

  • RESEARCH
  • ASTHMA
  • Published:
Lung Aims and scope Submit manuscript

Abstract

Background

Gene expression can provide distinct information compared to clinical biomarkers in the context of longitudinal clinical outcomes in asthma patients.

Objective

This study examined the association between the gene expression levels of upstream (IL-25, IL-33, and TSLP) and downstream cytokines (IL-5, IL-4, and IL-13) in the T2 inflammatory pathway with a 12-month follow-up of exacerbation, lung function, and steroid use.

Methods

Transcriptomic sequencing analysis was performed on peripheral blood mononuclear cells from 279 adult asthmatics. Survival analysis and linear mixed-effect models were used to investigate potential differences between the high-level and low-level gene expression groups and the clinical outcomes. Analysis was performed separately for the upstream, downstream, and all 6 cytokines.

Results

In general, T2 inflammatory cytokine gene expression showed a weak correlation with blood eosinophil counts (all r < 0.1) and clinical outcomes. Among moderate-to-severe eosinophilic asthma (MSEA) patients, individuals with elevated levels of downstream cytokines were at increased risk of time-to-first exacerbation (p = 0.044) and a greater increase of inhaled corticosteroid use over time (p = 0.002) compared to those with lower gene expression. There was no association between baseline T2 inflammatory cytokine gene expression and the longitudinal changes in lung function over time among MSEA patients.

Conclusion

These findings suggest that, among MSEA patients, the gene expression levels of downstream cytokines in the T2 inflammatory pathway may serve as indicators for endoty** asthma.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price includes VAT (United Kingdom)

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

Abbreviations

ACT:

Asthma control test

BEC:

Blood eosinophil count

Bude_eq:

Budesonide equivalent dose

COREA:

Cohort for Reality and Evolution of Adult Asthma in Korea

FeNO:

Fractional exhaled nitric oxide

FEV:

Forced expiratory volume in the first second

ICS:

Inhaled corticosteroids

IL:

Interleukin

MSEA:

Moderate-to-severe eosinophilic asthma

OCS:

Oral systemic steroids

PBMC:

Peripheral blood mononuclear cells

Pred_eq:

Prednisolone equivalent dose

TSLP:

Thymic stromal lymphopoietin

References

  1. Kuruvilla ME, Lee FE, Lee GB (2019) Understanding asthma phenotypes, endotypes, and mechanisms of disease. Clin Rev Allergy Immunol 56(2):219–233

    Article  PubMed  PubMed Central  Google Scholar 

  2. Hammad H, Lambrecht BN (2021) The basic immunology of asthma. Cell 184(9):2521–2522

    Article  CAS  PubMed  Google Scholar 

  3. Coverstone AM, Seibold MA, Peters MC (2020) Diagnosis and management of T2-high asthma. J Allergy Clin Immunol Pract 8(2):442–450

    Article  PubMed  Google Scholar 

  4. Busse WW, Viswanathan R (2022) What has been learned by cytokine targeting of asthma? J Allergy Clin Immunol 150(2):235–249

    Article  CAS  PubMed  Google Scholar 

  5. Lambrecht BN, Hammad H, Fahy JV (2019) The cytokines of asthma. Immunity 50(4):975–991

    Article  CAS  PubMed  Google Scholar 

  6. Dimitrova D, Youroukova V, Ivanova-Todorova E, Tumangelova-Yuzeir K, Velikova T (2019) Serum levels of IL-5, IL-6, IL-8, IL-13 and IL-17A in pre-defined groups of adult patients with moderate and severe bronchial asthma. Respir Med 154:144–154

    Article  PubMed  Google Scholar 

  7. Joseph J, Benedict S, Safa W, Joseph M (2004) Serum interleukin-5 levels are elevated in mild and moderate persistent asthma irrespective of regular inhaled glucocorticoid therapy. BMC Pulm Med 4:2

    Article  PubMed  PubMed Central  Google Scholar 

  8. Kuo CS, Pavlidis S, Loza M, Baribaud F, Rowe A, Pandis I et al (2017) T-helper cell type 2 (Th2) and non-Th2 molecular phenotypes of asthma using sputum transcriptomics in U-BIOPRED. Eur Respir J 49(2):1602135

    Article  PubMed  Google Scholar 

  9. Lee HW, Baek MG, Choi S, Ahn YH, Bang JY, Sohn KH et al (2022) Peripheral blood transcriptomic clusters uncovered immune phenotypes of asthma. Respir Res 23(1):237

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Peters MC, Mekonnen ZK, Yuan SP, Bhakta NR, Woodruff PG, Fahy JV (2014) Measures of gene expression in sputum cells can identify T2-high and T2-low subtypes of asthma. J Allergy Clin Immun 133(2):388-U181

    Article  CAS  PubMed  Google Scholar 

  11. Kuo CS, Pavlidis S, Loza M, Baribaud F, Rowe A, Pandis I et al (2017) A Transcriptome-driven analysis of epithelial brushings and bronchial biopsies to define asthma phenotypes in U-BIOPRED. Am J Respir Crit Care Med 195(4):443–455

    Article  CAS  PubMed  Google Scholar 

  12. Peters MC, Ringel L, Dyjack N, Herrin R, Woodruff PG, Rios C et al (2019) A transcriptomic method to determine airway immune dysfunction in T2-High and T2-Low Asthma. Am J Resp Crit Care 199(4):465–477

    Article  CAS  Google Scholar 

  13. Liew CC, Ma J, Tang HC, Zheng R, Dempsey AA (2006) The peripheral blood transcriptome dynamically reflects system wide biology: a potential diagnostic tool. J Lab Clin Med 147(3):126–132

    Article  CAS  PubMed  Google Scholar 

  14. Kim TB, Park CS, Bae YJ, Cho YS, Moon HB, Group CS. Factors associated with severity and exacerbation of asthma: a baseline analysis of the cohort for reality and evolution of adult asthma in Korea (COREA). Ann Allergy Asthma Immunol 2009; 103 (4): 311-317

  15. Wan Y, Qu K, Ouyang Z, Chang HY (2013) Genome-wide map** of RNA structure using nuclease digestion and high-throughput sequencing. Nat Protoc 8(5):849–869

    Article  CAS  PubMed  Google Scholar 

  16. Global initiative for asthma. global strategy for asthma management and prevention. 2022. https://ginasthma.org/wp-content/uploads/2022/07/GINA-Main-Report-2022-FINAL-22-07-01-WMS.pdf. Date last accessed: June 2023

  17. Gauvreau GM, O’Byrne PM, Boulet LP, Wang Y, Cockcroft D, Bigler J et al (2014) Effects of an anti-TSLP antibody on allergen-induced asthmatic responses. N Engl J Med 370(22):2102–2110

    Article  PubMed  Google Scholar 

  18. Menzies-Gow A, Corren J, Bourdin A, Chupp G, Israel E, Wechsler ME et al (2021) Tezepelumab in adults and adolescents with severe. Uncontrolled Asthma N Engl J Med 384(19):1800–1809

    Article  CAS  PubMed  Google Scholar 

  19. Theofani E, Tsitsopoulou A, Morianos I, Semitekolou M (2023) Severe asthmatic responses: the impact of TSLP. Int J Mol Sci 24(8):7581

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Skrgat S, Malovrh MM, Sarc I, Silar M, Dimitric V, Korosec P. TSLP as biomarker in asthma patients. European Respiratory Journal 2015; 46.

  21. Svenningsen S, Nair P (2022) Persistent airway plugs: a call for clinical recognition and novel therapies. Am J Resp Crit Care 205(9):977–978

    Article  Google Scholar 

Download references

Funding

This research was supported by the Bio & Medical Technology Development Program of the National Research Foundation (NRF) funded by the Korean government (MSIT) (2019M3E5D3073365).

Author information

Authors and Affiliations

Authors

Contributions

TBK designed the study, applied for the project, and supervised the whole process. DDP analyzed the data and drafted the manuscript. ES and JEL collected the gene expression data, while JHL, WJS, HSK, and YSK collected clinical data. SHW designed and supervised the analysis of the gene expression data

Corresponding author

Correspondence to Tae-Bum Kim.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 763 KB)

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Pham, D.D., Shin, E., Lee, J.E. et al. Transcriptomic Expression of T2-Inflammation Genes in Peripheral Blood Mononuclear Cells and Longitudinal Clinical Outcomes in Asthma: Insights from the COREA Study. Lung (2024). https://doi.org/10.1007/s00408-024-00728-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s00408-024-00728-9

Keywords

Navigation